Educational Activities Archives

Polysubstance use has been more the rule than the exception in treating substance use problems. The problem can complicate treatment and add significantly to the morbidity of the disease. This webinar will review the co-occurrence of various drug use disorders and how to more effectively address the patient and treat the disorder.

Tim Brennan is director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke’s hospitals. He discusses the why and how of transitioning a patient from methadone to buprenorphine, and dispels some common misperceptions that patients and providers have about these treatments.

Only 10% of 12- to 17-year-olds in need of substance use treatment actually receive care. This is the same period when people are most likely to begin abusing drugs, and adolescent drug use is an important predictor of the development of a substance use disorder later in life. Amy Yule of Harvard Medical School explains what sets this population apart and how to approach treatment.

In this episode we’ll look at two new tools for the treatment of alcohol use disorder. Lori Ducharme introduces the NIAAA Alcohol Treatment Navigator, and Laura Fochtmann highlights a new APA Practice Guideline.

The collaborative care model is designed to increase access to mental health care by treating common conditions in primary care settings, which are often the front lines for diagnosing depression, anxiety, and PTSD. In light of the growing demand for treatment of substance use disorders, we explore the potential impact of the collaborative care model, since substance use disorders are also often first identified in a primary care setting.